1.444
price down icon3.73%   -0.056
 
loading
전일 마감가:
$1.50
열려 있는:
$1.5
하루 거래량:
1.05M
Relative Volume:
0.68
시가총액:
$454.58M
수익:
$6.23M
순이익/손실:
$-95.90M
주가수익비율:
-3.7026
EPS:
-0.39
순현금흐름:
$-68.47M
1주 성능:
-3.08%
1개월 성능:
+5.41%
6개월 성능:
+83.91%
1년 성능:
-13.53%
1일 변동 폭
Value
$1.435
$1.52
1주일 범위
Value
$1.41
$1.55
52주 변동 폭
Value
$0.6513
$2.17

Precigen Inc Stock (PGEN) Company Profile

Name
명칭
Precigen Inc
Name
전화
301-556-9900
Name
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
직원
25
Name
트위터
@precigen
Name
다음 수익 날짜
2025-03-19
Name
최신 SEC 제출 서류
Name
PGEN's Discussions on Twitter

PGEN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PGEN
Precigen Inc
1.44 454.58M 6.23M -95.90M -68.47M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.01 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
519.97 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.08 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
563.58 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
266.35 28.51B 3.81B -644.79M -669.77M -6.24

Precigen Inc Stock (PGEN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-03-22 다운그레이드 JP Morgan Neutral → Underweight
2023-05-23 개시 JP Morgan Neutral
2022-11-18 개시 Cantor Fitzgerald Overweight
2021-02-25 개시 Stifel Buy
2021-02-22 개시 Wells Fargo Overweight
2021-02-18 개시 B. Riley Securities Buy
2020-05-08 개시 H.C. Wainwright Buy
모두보기

Precigen Inc 주식(PGEN)의 최신 뉴스

pulisher
Jun 18, 2025

Closing Strong: Precigen Inc (PGEN) Ends at 1.42, Down -7.79 from Last Close - DWinneX

Jun 18, 2025
pulisher
Jun 16, 2025

High Growth Tech Stocks To Watch In The US June 2025 - simplywall.st

Jun 16, 2025
pulisher
Jun 15, 2025

Bank of America Corp DE Has $232,000 Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Precigen stock price target maintained at $6 by JMP on RRP therapy - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 13, 2025

Precigen’s SWOT analysis: gene therapy firm’s stock poised for potential breakthrough - Investing.com Australia

Jun 13, 2025
pulisher
Jun 13, 2025

Precigen (NASDAQ:PGEN) Given “Market Outperform” Rating at JMP Securities - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

JMP Securities Reiterates PGEN with Market Outperform Rating | P - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

JMP Securities Reiterates PGEN with Market Outperform Rating | PGEN Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Precigen, Inc.'s (NASDAQ:PGEN) market cap touched US$455m last week, benefiting both private equity firms who own 33% as well as institutions - Yahoo Finance

Jun 12, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Weighs in on Precigen FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 06, 2025

BNP Paribas Financial Markets Acquires New Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

ProShare Advisors LLC Buys 10,900 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World

Jun 04, 2025
pulisher
Jun 01, 2025

Top 5 Synthetic Biology Public Companies (June 2025) - Securities.io

Jun 01, 2025
pulisher
May 31, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Acquired by Cetera Investment Advisers - Defense World

May 31, 2025
pulisher
May 28, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Purchased by Northern Trust Corp - Defense World

May 28, 2025
pulisher
May 26, 2025

D. E. Shaw & Co. Inc. Sells 792,731 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World

May 26, 2025
pulisher
May 24, 2025

Precigen (NASDAQ:PGEN) Downgraded to “Sell” Rating by Wall Street Zen - Defense World

May 24, 2025
pulisher
May 20, 2025

Precigen, Inc. Reports Q1 2025 Financial Results - TipRanks

May 20, 2025
pulisher
May 19, 2025

FY2025 EPS Estimates for Precigen Cut by Cantor Fitzgerald - Defense World

May 19, 2025
pulisher
May 19, 2025

HC Wainwright Decreases Earnings Estimates for Precigen - Defense World

May 19, 2025
pulisher
May 18, 2025

FY2027 EPS Estimates for Precigen Reduced by HC Wainwright - Defense World

May 18, 2025
pulisher
May 18, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World

May 18, 2025
pulisher
May 17, 2025

Cantor Fitzgerald Reiterates “Overweight” Rating for Precigen (NASDAQ:PGEN) - Defense World

May 17, 2025
pulisher
May 16, 2025

Precigen First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

Stifel Financial Corp Acquires 58,657 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World

May 16, 2025
pulisher
May 15, 2025

Cantor Fitzgerald maintains Overweight on Precigen stock By Investing.com - Investing.com South Africa

May 15, 2025
pulisher
May 15, 2025

Precigen (PGEN) Rating Reaffirmed as Overweight by Cantor Fitzge - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Precigen (PGEN) Rating Reaffirmed as Overweight by Cantor Fitzgerald | PGEN Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

JMP maintains Precigen stock $6 target on PRGN-2012 optimism By Investing.com - Investing.com Nigeria

May 15, 2025
pulisher
May 15, 2025

JMP maintains Precigen stock $6 target on PRGN-2012 optimism - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald maintains Overweight on Precigen stock - Investing.com

May 15, 2025
pulisher
May 14, 2025

Precigen Reports First Quarter 2025 Financial Results and Business Updates - StreetInsider

May 14, 2025
pulisher
May 14, 2025

Precigen Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

Precigen Inc (PGEN) Q1 2025 Earnings: Revenue Surges 26% to $1.4 - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Precigen Reports First Quarter 2025 Financial Results and Busine - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Precigen Reports First Quarter 2025 Financial Results and Business Updates | PGEN Stock News - GuruFocus

May 14, 2025
pulisher
May 12, 2025

Barclays PLC Purchases 53,546 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World

May 12, 2025
pulisher
May 11, 2025

Precigen (PGEN) to Release Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 11, 2025

Wells Fargo & Company MN Increases Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World

May 11, 2025
pulisher
May 10, 2025

Precigen : to Announce First Quarter 2020 Financial Results on May 6th - marketscreener.com

May 10, 2025
pulisher
May 09, 2025

Precigen Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView

May 09, 2025
pulisher
May 02, 2025

LPL Financial LLC Trims Stock Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World

May 02, 2025
pulisher
May 01, 2025

Precision BioSciences Announces Multiple Presentations for In Vivo Gene Editing Programs at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Business Wire

May 01, 2025
pulisher
Apr 30, 2025

There is no way Precigen Inc (PGEN) can keep these numbers up - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Precigen, Inc. (NASDAQ:PGEN) Shares Sold by Renaissance Technologies LLC - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

Precigen Inc [PGEN] Insider Activity: An Update for Investors - knoxdaily.com

Apr 29, 2025
pulisher
Apr 29, 2025

Precigen Inc (PGEN) stock analysis: A comprehensive overview - uspostnews.com

Apr 29, 2025
pulisher
Apr 28, 2025

Geode Capital Management LLC Acquires 53,343 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World

Apr 28, 2025
pulisher
Apr 28, 2025

JPMorgan Chase & Co. Lowers Stock Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World

Apr 28, 2025
pulisher
Apr 25, 2025

Intrexon : Precigen Completes Series Of Transactions To Solidify Healthcare Focus - marketscreener.com

Apr 25, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025

Precigen Inc (PGEN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Precigen Inc 주식 (PGEN) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Perez Jeffrey Thomas
SVP, IP Affairs
Aug 09 '24
Buy
0.85
58,823
50,000
743,097
KIRK RANDAL J
Director
Aug 09 '24
Buy
0.85
23,529,411
19,999,999
64,547,214
$20.48
price down icon 1.21%
$35.87
price down icon 0.73%
$21.02
price up icon 0.67%
$104.90
price down icon 1.02%
$102.67
price down icon 2.16%
biotechnology ONC
$266.38
price up icon 0.07%
자본화:     |  볼륨(24시간):